Clinical assessment incorporating a personal genome

Keyphrases

• Genetic Risk 100%
• Clinical Assessment 100%
• Personal Genome 100%
• Coronary Artery Disease 66%
• Drug Response 66%
• Family History 66%
• Sudden Cardiac Death 66%
• Pretest Probability 66%
• Pharmacogenomics 33%
• Clinical Setting 33%
• Genetic Analysis 33%
• Clinically Significant 33%
• Warfarin 33%
• Type 2 Diabetes Mellitus (T2DM) 33%
• Single nucleotide Polymorphism 33%
• Risk Prediction 33%
• Vascular Disease 33%
• Rare Variants 33%
• Pathogenicity 33%
• Clopidogrel Resistance 33%
• Disease-specific 33%
• CYP2C19 33%
• Gene-environment Interaction 33%
• Likelihood Ratio 33%
• Children's Health 33%
• Genetic Counseling 33%
• Copy number Variation 33%
• Human Genome 33%
• Whole Genome Sequencing 33%
• U.S. National Library of Medicine 33%
• Sudden Death 33%
• Null mutation 33%
• Risk Analysis 33%
• Lipid-lowering Therapy 33%
• Disease Response 33%
• Common Variants 33%
• Genomic Information 33%
• Whole Genome 33%
• Heart Blood 33%
• Cardiac Genes 33%
• Positive Responses 33%
• Clinical Risk 33%
• VKORC1 33%
• Clinical Translation 33%
• Disease Analysis 33%
• Specific mutation 33%
• Medical Sciences 33%
• Mendelian Disease 33%
• Age-appropriate 33%
• Disease Screening 33%
• CYP4F2 33%
• Type 2 Myocardial Infarction 33%
• MYBPC3 33%
• Family Foundations 33%
• Mutation Database 33%
• National Human Genome Research Institute 33%
• Interdependent Risks 33%
• Sequence Risk 33%
• Hewlett Packard 33%
• TMEM43 33%
• Infection Probability 33%
• Medical Institutes 33%
• Novel Variant 33%
• Risk Estimate 33%
• National Heart Lung 33%
• Full Genome Sequence 33%

Biochemistry, Genetics and Molecular Biology

• Genetic Risk 100%
• Drug Response 66%
• Human Genome 66%
• Sudden Cardiac Death 66%
• Coronary Artery Disease 66%
• Genetics 33%
• Lipid 33%
• Single-Nucleotide Polymorphism 33%
• Whole Genome Sequencing 33%
• Clopidogrel 33%
• Pharmacogenomics 33%
• Copy-Number Variation 33%
• Genetic Counseling 33%
• Child Health 33%
• CYP2C19 33%
• Gene-Environment Interaction 33%
• VKORC1 33%
• CYP4F2 33%
• TMEM43 33%
• Genomics 33%
• Rare Variant 33%
• Maturity Onset Diabetes of the Young 33%
• Common Variant 33%